Conclusion: These analyses provide robust estimates of the expected blood pressure-lowering effect for any combination of antihypertensive drugs, allowing their efficacy to be classified into low, moderate, and high intensity.
PubMed 40885583 ↗Beta Blockers
The short answer. There isn't much data on Beta Blockers yet — 25 mentions, 11 with a clear outcome — so treat these numbers as anecdotal. It is most often used for anxiety: 83% of 12 reports say that improved. It is well studied — 1,120 meta-analyses on PubMed.
From 25 mentions in total — the rest didn't say how it went and aren't counted.
What Beta Blockers does, according to users
Of the people who reported each effect, the share who said it got better.
What the research says
Systematic reviews and meta-analyses from PubMed, with their published conclusions.
3+ meta-analyses or systematic reviews and 10+ randomized controlled trials in humans. The grade measures how much human research exists — read the conclusions below for what it found. 1,120 meta-analyses on PubMed ↗ · 1,851 randomized trials ↗
Conclusion: In patients with HF with reduced ejection fraction, the estimated aggregate benefit is greatest for a combination of ARNi, BB, MRA, and SGLT2i.
PubMed 34895860 ↗Conclusion: Blood pressure lowering significantly reduces vascular risk across various baseline blood pressure levels and comorbidities. Our results provide strong support for lowering blood pressure to systolic blood pressures less than 130 mm Hg and providing blood pressure lowering treatment to individuals with a history of cardiovascular disease, coronary heart disease, stroke, diabetes, heart failure, and chronic kidney disease.
PubMed 26724178 ↗Conclusion: (CGRP(r)mAbs) have the best safety and efficacy profile of all drugs for migraine prophylaxis, followed closely by gepants.
PubMed 37208596 ↗770 human trials on ClinicalTrials.gov test Beta Blockers — 327 completed, 110 recruiting now. See all on ClinicalTrials.gov ↗
- Predicting Early Circulatory Deterioration After Short-Acting Beta-Blocker Treatment in Intensive Care Patients · Critical Illness · 2026
- Catheter Ablation Versus Medical Treatment of AF in Heart Failure · Atrial Fibrillation, Heart Failure · 2013
- BAROSTIM NEO Hypertension Pivotal Trial · Uncontrolled Hypertension · 2025
What government agencies say
Official records from US, Canadian and EU regulators, each linked to its source.
NIH has funded 19 research projects with Beta Blockers in the title, $9,238,090 in total (1985–2025). NIH RePORTER ↗
Dosage people report
Reported side effects
How often each side effect came up across all reports.
What users say
First-hand experiences, quoted verbatim. We show one positive and one negative where both exist.
“beta blockers were truly the catalyst that helped me break through to a normal life... absolutely no chance of a racing heart”
“Beta blockers. I'm not advocating for their use, but answering your question objectively. They're renowned for helping public speakers.”
“I managed to survive with a help of beta blockers and adaptogens... they make me more quiet, it's like I don't even feel like starting conversations.”
“Have you ever tried beta blockers? They’ve been a godsend for situational anxiety for me”
Top discussions (5)
- supplements that ACTUALLY work well for anxiety? ↗
- Most effective and profoundly noticeable psychotropic substance for reducing Social Anxiety? ↗
- Sleep stack that does not help after quitting marijuana insomnia. ↗
- This subreddit is turning increasingly delusional. What the FUCK people? ↗
- High dose L-theanine ↗
Other options for anxiety
Sources
- User reports: 25 mentions in public discussions, quoted with a link to each discussion (e.g. this thread ↗).
- PubMed (US National Library of Medicine, NIH): meta-analyses ↗ · randomized trials ↗
- ClinicalTrials.gov (NIH): registered trials ↗
- NIH RePORTER ↗
User data from public discussions; research from PubMed. Information only, not medical advice — talk to a doctor before starting, stopping or combining anything. Data updated October 5, 2026. How we rate